Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Lilly's new AMPA antagonist, LY-311446

Aug. 30, 1996

PLA2 role in Alzheimer's disease suggested

Aug. 30, 1996

Pfizer reports new class of muscarinic agonists

Aug. 30, 1996

CRM-1.13.1: Nicotinic agonist based on lobeline

Aug. 30, 1996

CGP-25454 tested in healthy volunteers

Aug. 30, 1996

Correlation established between serum PLA2 activity and schizophrenia symptoms

Aug. 30, 1996

Potential antipsychotic described by Parke-Davis

Aug. 30, 1996

Famotidine tested in schizophrenic patients

Aug. 30, 1996

DuPont Merck reports on CRH antagonists for anxiety, depression

Aug. 30, 1996

Russian investigators describe new tranquilizer

Aug. 30, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...